ROCKWELL MEDICAL, INC. Increase (Decrease) in Deferred Revenue
ROCKWELL MEDICAL, INC. (RMTI) reported Increase (Decrease) in Deferred Revenue of -$572.71 thousand for the 3-month period ending 2018-03-31, per its 10-Q/A filed 2018-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-08-14
- ROCKWELL MEDICAL, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$572.71K.
- ROCKWELL MEDICAL, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$604.67K.
- ROCKWELL MEDICAL, INC. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$498.12K.
- ROCKWELL MEDICAL, INC. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was -$498.12K.
- ROCKWELL MEDICAL, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$2.10M.
- ROCKWELL MEDICAL, INC. increase (decrease) in deferred revenue for fiscal 2016 was -$2.07M.
- ROCKWELL MEDICAL, INC. increase (decrease) in deferred revenue for fiscal 2015 was -$2.08M, a 110.68% decline from fiscal 2014.
- ROCKWELL MEDICAL, INC. increase (decrease) in deferred revenue for fiscal 2014 was $19.49M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|---|
| 2018-03-31 | -$572.71K 10-Q/A · filed 2018-08-14 | -$504.53K 10-Q · filed 2018-05-10 | -$1.18M derived: sum of 2 quarters · filed 2018-08-14 | -$1.68M derived: sum of 3 quarters · filed 2018-08-14 | -$2.17M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-12-31 | -$604.67K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$1.10M derived: sum of 2 quarters · filed 2018-03-15 | -$1.60M derived: sum of 3 quarters · filed 2018-03-15 | -$2.10M 10-K · filed 2018-03-15 | ||
| 2017-09-30 | -$498.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$996.24K derived: sum of 2 quarters · filed 2017-11-08 | -$1.49M 10-Q · filed 2017-11-08 | -$2.12M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-06-30 | -$498.12K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-08-09 | -$996.24K 10-Q · filed 2017-08-09 | -$1.62M derived: sum of 3 quarters · filed 2018-08-14 | -$2.10M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | -$498.12K 10-Q/A · filed 2018-08-14 | -$1.12M derived: sum of 2 quarters · filed 2018-08-14 | -$1.60M derived: sum of 3 quarters · filed 2018-08-14 | -$2.08M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2016-12-31 | -$620.73K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$1.10M derived: sum of 2 quarters · filed 2018-03-15 | -$1.58M derived: sum of 3 quarters · filed 2018-03-15 | -$2.07M 10-K · filed 2018-03-15 | ||
| 2016-09-30 | -$481.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$963.37K derived: sum of 2 quarters · filed 2017-11-08 | -$1.45M 10-Q · filed 2017-11-08 | $2.37M 10-Q · filed 2016-11-07 | -$2.05M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-06-30 | -$481.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$963.37K 10-Q · filed 2017-08-09 | -$1.57M derived: sum of 3 quarters · filed 2018-03-15 | |||
| 2016-03-31 | -$481.69K 10-Q · filed 2017-05-09 | -$1.08M derived: sum of 2 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | -$601.99K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$2.08M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | -$1.48M 10-Q · filed 2016-11-07 | |||||
| 2014-12-31 | $19.49M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |